📋 Tender Overview
Precision Medicine Platform In Neurodegenerative Disease
Opening The Door To Personalised Medicine For Dementiapersonalised Medicine Takes Into Account Individual Variability And Unique Characteristics Such As A Person’S Genetic Makeup, Biomarkers, And Personal Health Data To Provide Tailored Treatment And Preventive Strategies. Although Personalised Medicine Holds Great Potential, The Lack Of Appropriate Tools Has Impeded Its Implementation. Funded By The Horizon Programme, The Prominent Project Aims To Develop A Digital Platform For Precision Medicine, Addressing Barriers In Utilising Advanced Diagnostics And Disease-Modifying Therapies. The Platform Will Encompass Prediction Models That Rely On Various Diagnostic Data Sources And It Will Focus On Neurodegenerative Disorders Which Are Increasing In Prevalence Due To The Ageing Population. The Expected Outcomes Include Enhanced Diagnostic Precision, Improved Application Of New Treatment Options, And Improved Health Outcomes.
Funded Under
Health
Total Cost
€ 11 069 750,00
Eu Contribution
€ 6 069 750,00
Coordinated By
Karolinska Institutet
Sweden
